Financhill
Sell
34

VOPKF Quote, Financials, Valuation and Earnings

Last price:
$43.70
Seasonality move :
1.35%
Day range:
$43.70 - $43.70
52-week range:
$37.60 - $50.60
Dividend yield:
4.16%
P/E ratio:
9.89x
P/S ratio:
3.58x
P/B ratio:
1.66x
Volume:
200
Avg. volume:
460
1-year change:
-7.02%
Market cap:
$5B
Revenue:
$1.4B
EPS (TTM):
$4.50

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Royal Vopak NV has -- downside to fair value with a price target of -- per share.

VOPKF vs. S&P 500

  • Over the past 5 trading days, Royal Vopak NV has overperformed the S&P 500 by 0.77% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Royal Vopak NV does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Royal Vopak NV has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Royal Vopak NV reported revenues of --.

Earnings Growth

  • Royal Vopak NV has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Royal Vopak NV reported earnings per share of --.
Enterprise value:
8.4B
EV / Invested capital:
--
Price / LTM sales:
3.58x
EV / EBIT:
10.41x
EV / Revenue:
5.81x
PEG ratio (5yr expected):
0.27x
EV / Free cash flow:
14.56x
Price / Operating cash flow:
11.51x
Enterprise value / EBITDA:
7.29x
Gross Profit (TTM):
$370.9M
Return On Assets:
7.28%
Net Income Margin (TTM):
39.97%
Return On Equity:
15.35%
Return On Invested Capital:
9.25%
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2024-01-02 2025-01-02 2025-01-02
Income Statement
Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
Operating Income -- -- -- -- --
EBITDA -- -- -- -- --
Diluted EPS -- -- -- -- --
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Balance Sheet
Current Assets $546.3M $546.3M $484.1M $488.1M $555.5M
Total Assets $8.1B $7.3B $7.4B $7.1B $7.8B
Current Liabilities $1.2B $1.1B $998.3M $1.1B $721.6M
Total Liabilities $4.4B $4.2B $4B $3.7B $4.2B
Total Equity $3.7B $3.1B $3.4B $3.5B $3.6B
Total Debt $2.7B -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2020-06-30 2021-06-30 2022-06-30 2021-06-30 2022-06-30
Cash Flow Statement
Cash Flow Operations -- $635.9M $803M -- $339.9M
Cash From Investing -- -$263.9M -$643.9M -- -$288.4M
Cash From Financing -- -$353M -$152.8M -- -$60.5M
Free Cash Flow -- -$37.7M $306.2M -- --
VOPKF
Sector
Market Cap
$5B
$34.8M
Price % of 52-Week High
86.36%
68.89%
Dividend Yield
4.16%
0%
Shareholder Yield
7.63%
0.03%
1-Year Price Total Return
-7.02%
-3.33%
Beta (5-Year)
0.664
0.424
Dividend yield:
4.16%
Annualized payout:
$1.61
Payout ratio:
-35.51%
Growth streak:
2 years

Technicals

8-day SMA
Sell
Level $44.01
200-day SMA
Sell
Level $45.36
Bollinger Bands (100)
Sell
Level 43.81 - 47.41
Chaikin Money Flow
Buy
Level 4.7K
20-day SMA
Sell
Level $44.01
Relative Strength Index (RSI14)
Sell
Level 37.10
ADX Line
Sell
Level 22.76
Williams %R
Buy
Level -100
50-day SMA
Sell
Level $44.75
MACD (12, 26)
Buy
Level 12.11
25-day Aroon Oscillator
Buy
Level 88
On Balance Volume
Neutral
Level 2.6K

Financial Scores

Hold
Altman Z-Score (Annual)
Level (1.8234)
Sell
CA Score (Annual)
Level (-0.3021)
Buy
Beneish M-Score (Annual)
Level (-2.8165)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-0.078)
Buy
Piotroski F Score (Annual)
Level (6)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Royal Vopak NV operates as an independent tank storage company. It operates through the following segments: Asia & Middle East; China & North Asia; Netherlands, Singapore; USA & Canada and All Other Business Units. The company was founded in 1999 and is headquartered in Rotterdam, the Netherlands.

Stock Forecast FAQ

In the current month, VOPKF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The VOPKF average analyst price target in the past 3 months is --.

  • Where Will Royal Vopak NV Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Royal Vopak NV share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Royal Vopak NV?

    Analysts are divided on their view about Royal Vopak NV share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Royal Vopak NV is a Sell and believe this share price will rise from its current level to --.

  • What Is Royal Vopak NV's Price Target?

    The price target for Royal Vopak NV over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is VOPKF A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Royal Vopak NV is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of VOPKF?

    You can purchase shares of Royal Vopak NV via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Royal Vopak NV shares.

  • What Is The Royal Vopak NV Share Price Today?

    Royal Vopak NV was last trading at $43.70 per share. This represents the most recent stock quote for Royal Vopak NV. Yesterday, Royal Vopak NV closed at $43.70 per share.

  • How To Buy Royal Vopak NV Stock Online?

    In order to purchase Royal Vopak NV stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
30
CORT alert for Jan 2

Corcept Therapeutics, Inc. [CORT] is up 5.4% over the past day.

Buy
75
AXSM alert for Jan 2

Axsome Therapeutics, Inc. [AXSM] is down 3.78% over the past day.

Sell
50
NUTX alert for Jan 2

Nutex Health, Inc. [NUTX] is down 8.96% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock